| 1 |
31550496 | A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation. | 2020 Feb |
1 |
| 2 |
31580501 | Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. | 2020 Jan 15 |
1 |
| 3 |
31880407 | Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia. | 2020 Feb |
2 |
| 4 |
31919472 | FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions. | 2020 Mar |
1 |
| 5 |
31692922 | Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells. | 2019 Oct 22 |
1 |
| 6 |
31893105 | Sorafenib for relapsed FLT3-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis. | 2019 Dec |
1 |